ResMed Inc. RMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.12% | -3.84% | 1.56% | 12.64% | -8.21% |
| Total Depreciation and Amortization | 6.14% | -22.00% | 11.92% | 9.11% | -24.54% |
| Total Amortization of Deferred Charges | -- | -2.18% | 0.55% | -0.11% | 0.90% |
| Total Other Non-Cash Items | -237.74% | -30.56% | 29.82% | 4.86% | -0.60% |
| Change in Net Operating Assets | -69.14% | -116.35% | 135.96% | -663.43% | -57.02% |
| Cash from Operations | -7.08% | -17.96% | 63.10% | -25.71% | -15.12% |
| Capital Expenditure | 4.67% | -51.92% | -17.92% | 33.58% | -40.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 97.70% | -1,207.39% | -- | 100.00% | 99.62% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 64.77% | -1,515.52% | 102.27% | -146.43% | -125.64% |
| Cash from Investing | 202.19% | -561.15% | -13.91% | 3.11% | 60.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4,900.00% | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -87.53% | 294.70% | -74.87% | 260.23% | -72.79% |
| Repurchase of Common Stock | -367.44% | -14.23% | 10.18% | -29.58% | -49.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.03% | 0.17% | 0.40% | 0.19% | -13.09% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -385.63% | -3.10% | 1.20% | -12.19% | -40.51% |
| Foreign Exchange rate Adjustments | 456.24% | -64.95% | -6.69% | 3,997.18% | -100.20% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -139.70% | -178.57% | 632.80% | -80.95% | -36.98% |